Detalhe da pesquisa
1.
Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry.
Lab Invest
; 100(6): 874-886, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31896815
2.
Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
BMC Pulm Med
; 20(1): 205, 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736614
3.
Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
Br J Cancer
; 116(5): 592-599, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095398
4.
The effect of time changes in diagnosing lung cancer type on its recorded distribution, with particular reference to adenocarcinoma.
Regul Toxicol Pharmacol
; 81: 322-333, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664320
5.
Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.
Hum Mol Genet
; 22(16): 3207-17, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591990
6.
BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
Histopathology
; 64(4): 547-56, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266897
7.
Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.
J Clin Pathol
; 77(2): 135-139, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604178
8.
Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer.
J Clin Pathol
; 77(2): 140-144, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071529
9.
Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.
J Clin Pathol
; 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258251
10.
Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).
Histopathology
; 59(4): 751-62, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22014055
11.
Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety.
J Clin Pathol
; 74(1): 64-66, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482888
12.
Biomarker Testing for People With Advanced Lung Cancer in England.
JTO Clin Res Rep
; 2(6): 100176, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590024
13.
Cytology for PD-L1 testing: A systematic review.
Lung Cancer
; 141: 101-106, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007657
14.
Programmed death ligand 1 expression in EBUS aspirates of non-small cell lung cancer: Is interpretation affected by type of fixation?
Cancer Cytopathol
; 128(2): 100-106, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851430
15.
Increased expression of Id family proteins in small cell lung cancer and its prognostic significance.
Clin Cancer Res
; 14(8): 2318-25, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18413820
16.
An unusual cause of multiple pulmonary nodules: glomus tumors of the lung.
Lung
; 192(4): 629-30, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714807
17.
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response.
Lung Cancer
; 134: 79-84, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320000
18.
Making light of an interstitial process.
Am J Respir Crit Care Med
; 186(9): 926, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23118084
19.
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?
ESMO Open
; 3(6): e000419, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30245863
20.
COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.
J Cancer Res Clin Oncol
; 143(7): 1133-1141, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28258342